Supplement comparison results

Primary ingredients How we evaluate

We verify HCA content (mg) per daily intake and standardization ratio (%) within product. We consider 1,500 mg HCA daily or less appropriate per regulatory guidance, and verify 50-60% standardization rate clarity. We review raw material source (India, Sri Lanka) and variety, and batch consistency management.

Price How we evaluate

We calculate per-tablet unit price to compare ingredient-based cost-effectiveness. We reflect actual HCA absorption, standardization level, and formulation efficiency in practical value assessment. We compare same-price-range products considering ingredient marking credibility and raw material/process transparency.

Brand How we evaluate

We confirm health functional food labeling and basic GMP/HACCP certifications, and review additional domestic and international certifications, raw material/manufacturing country disclosure, and product traceability. We evaluate self-testing data publication (component analysis reports), batch-specific test reports (CoA) provision, and customer inquiry response systems.

Quality How we evaluate

We verify standardization basis and test method specification, and confirm label marking to actual content correspondence. We examine safety testing (residual solvent, heavy metal, microorganism) and product stability testing (accelerated, real-time) conduct. We check packaging oxygen/moisture barrier performance (aluminum pouch, dark packaging, etc.), individual packaging presence, capsule size, and disintegration time. We verify unnecessary auxiliary/excessive additive avoidance and batch quality consistency.

Additional ingredients How we evaluate

We verify balanced inclusion of weight management-supporting components (B vitamins, chromium, dietary fiber, etc.). We confirm clear labeling of each component content and origin, and unnecessary sweetener/flavor/color/caffeine absence. We avoid stimulant components (excess caffeine, synephrine, etc.) and evaluate stomach-burden reduction design. We review individual characteristic (pregnancy/nursing, specific disease, medication use) caution labeling.